Onconova Therapeutics competitors

Onconova Therapeutics Competitors include Provectus Biopharmaceuticals, Exelixis, Genocea Biosciences and Inspyr Therapeutics.
Add company...
Onconova Therapeutics
Onconova Therapeutics
Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer.
Provectus Biopharmaceuticals
Provectus Biopharmaceuticals
Provectus Biopharmaceuticals, Inc., specializes in developing oncology and dermatology therapies.
Exelixis
Exelixis
Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
Inspyr Therapeutics
Inspyr Therapeutics
Inspyr Therapeutics is a development-stage pharmaceutical company focused on therapeutics that deliver a cancer-destroying drug directly to the tumor or its supporting environment, the tumor vasculature.
Founding Date
Founding Date
1998
Founding Date
2002
Founding Date
1994
Founding Date
2006
Founding Date
1903
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Newtown, US HQ
Locations
Knoxville, US HQ
Locations
South San Francisco, US HQ
Locations
Cambridge, US HQ
Locations
Westlake Village, US HQ
Employees
Employees
259% increase
Employees
4
Employees
287
Employees
5247% decrease
Employees
2
Valuation ($)
Valuation ($)
13 m
Valuation ($)
20.2 m
Valuation ($)
6.8 b
Valuation ($)
52.4 m
Valuation ($)
41.9 k
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
4.5 k
Twitter followers
698
Twitter followers
401

Financial

Revenue (est.)
Revenue (est.)
$787k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$452.5m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($24.1m) (FY, 2017)
Net income
($13.5m) (FY, 2017)
Net income
$154.2m (FY, 2017)
Net income
($56.7m) (FY, 2017)
Net income
($3.6m) (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 88m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 209.5m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Provectus Biopharmaceuticals
HQ
Knoxville, US
Employees
4

Provectus Biopharmaceuticals, Inc., specializes in developing oncology and dermatology therapies.

View company
Exelixis
HQ
South San Francisco, US
Employees
287

Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.

View company
Genocea Biosciences
HQ
Cambridge, US
Employees
52↓ 47% decrease

Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.

View company
Inspyr Therapeutics
HQ
Westlake Village, US
Employees
2

Inspyr Therapeutics is a development-stage pharmaceutical company focused on therapeutics that deliver a cancer-destroying drug directly to the tumor or its supporting environment, the tumor vasculature.

View company